| Stage | NCLH | % of rev | CCL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.9B | 100.00% | $8.4B | 100.00% | CCL ×2.86 |
| Gross profit | $1.3B | 43.41% | $7.8B | 92.71% | CCL +49.3pp |
| Operating income | $624M | 21.19% | $2.2B | 26.32% | CCL +5.1pp |
| Pre-tax income | $485M | 16.45% | $1.9B | 22.99% | CCL +6.5pp |
| Net income | $491M | 16.68% | $1.9B | 22.80% | CCL +6.1pp |
| Stage | NCLH | CCL | Gap · A − B |
|---|---|---|---|
| Revenue | $2.9B100.00% | $8.4B100.00% | CCL ×2.86 |
| Gross profit | 43.41%$1.3B | 92.71%$7.8B | CCL +49.3pp |
| Operating income | 21.19%$624M | 26.32%$2.2B | CCL +5.1pp |
| Pre-tax income | 16.45%$485M | 22.99%$1.9B | CCL +6.5pp |
| Net income |
| 16.68%$491M |
| 22.80%$1.9B |
| CCL +6.1pp |